Aktienanalyse zu Qtrex Quantum Ltd (QTEX)QTEXQtrex Quantum Ltd

Qtrex Quantum Ltd, formerly known as Inspira Technologies Oxy B.H.N Ltd, is an Israel-based company engaged in medical and technological sectors. The Company is a specialty medical device company that is engaged in the research, development, manufacture, and marketing of respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV). The Company focuses on advancing non-invasive or minimally invasive respiratory support technologies intended to reduce reliance on mechanical ventilation and improve patient outcomes in acute care settings. The Firm provides patients with acute respiratory distress syndrome to maintain spontaneous breathing and avoid the various risks associated with the use of MV. It operates in the Healthcare sector.

QTEX is currently trading at $1.39 with a forward P/E of 8.25, indicating potential value, but the RSI is at 44.073, suggesting it is not yet oversold. The stock has experienced a significant year-to-date change of +265.79%, but it has recently declined by 7.33% over the last five days, indicating volatility. The main risk is the negative EPS forecast for Q4 2024 at -0.60, which could impact investor sentiment.